These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 1391765

  • 1. 5,7-DHT facilitated lordosis: effects of 5-HT agonists.
    Aiello-Zaldivar M, Luine V, Frankfurt M.
    Neuroreport; 1992 Jun; 3(6):542-4. PubMed ID: 1391765
    [Abstract] [Full Text] [Related]

  • 2. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ, Coscina DV, Fletcher PJ.
    Brain Res; 1998 Jul 27; 800(1):62-8. PubMed ID: 9685586
    [Abstract] [Full Text] [Related]

  • 3. Role of presynaptic serotonergic receptors on the mechanism of action of 5-HT1A and 5-HT1B agonists on masculine sexual behaviour: physiological and pharmacological implications.
    Fernández-Guasti A, Escalante A.
    J Neural Transm Gen Sect; 1991 Jul 27; 85(2):95-107. PubMed ID: 1834089
    [Abstract] [Full Text] [Related]

  • 4. Inhibitory effects of the 5-HT1A agonists, 5-hydroxy- and 5-methoxy-(3-di-n-propylamino)chroman, on female lordosis behavior.
    Uphouse L, Caldarola-Pastuszka M, Moore N.
    Neuropharmacology; 1993 Jul 27; 32(7):641-51. PubMed ID: 8361579
    [Abstract] [Full Text] [Related]

  • 5. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD, Li Q, Cabrera TM, Brownfield MS, Battaglia G.
    J Pharmacol Exp Ther; 1998 Jul 27; 286(1):256-62. PubMed ID: 9655867
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of the lordosis-inhibiting effects of 8-OH-DPAT by TFMPP and quipazine.
    Wolf A, Jackson A, Price T, Trevino A, Caldarola-Pastuszka M, Uphouse L.
    Brain Res; 1998 Sep 07; 804(2):206-11. PubMed ID: 9757039
    [Abstract] [Full Text] [Related]

  • 7. Attenuating effects of prior oestradiol benzoate priming on 5-HT-mediated lordosis behavior in rats are dose-dependent.
    Siddiqui A, Shaharyar S.
    Acta Physiol Hung; 2007 Sep 07; 94(3):209-21. PubMed ID: 17853773
    [Abstract] [Full Text] [Related]

  • 8. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K, Rivet JM, Millan MJ.
    J Pharmacol Exp Ther; 1993 Jan 07; 264(1):95-104. PubMed ID: 8423555
    [Abstract] [Full Text] [Related]

  • 9. Effects of the 5-HT1A agonist, 8-OH-DPAT, on sexual behaviors of the proestrous rat.
    Uphouse L, Montanez S, Richards-Hill R, Caldarola-Pastuszka M, Droge M.
    Pharmacol Biochem Behav; 1991 Jul 07; 39(3):635-40. PubMed ID: 1838412
    [Abstract] [Full Text] [Related]

  • 10. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W, Harrison L, Guptarak J, White S, Hiegel C, Uphouse L.
    Brain Res; 2003 Jun 06; 974(1-2):202-11. PubMed ID: 12742638
    [Abstract] [Full Text] [Related]

  • 11. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine.
    Sijbesma H, Schipper J, de Kloet ER, Mos J, van Aken H, Olivier B.
    Pharmacol Biochem Behav; 1991 Feb 06; 38(2):447-58. PubMed ID: 1829232
    [Abstract] [Full Text] [Related]

  • 12. 8-OH-DPAT influences extracellular levels of serotonin and dopamine in the medial preoptic area of male rats.
    Lorrain DS, Matuszewich L, Hull EM.
    Brain Res; 1998 Apr 20; 790(1-2):217-23. PubMed ID: 9593901
    [Abstract] [Full Text] [Related]

  • 13. 5-HT1A receptor antagonists and lordosis behavior.
    Uphouse L, Andrade M, Caldarola-Pastuszka M, Jackson A.
    Neuropharmacology; 1996 Apr 20; 35(4):489-95. PubMed ID: 8793912
    [Abstract] [Full Text] [Related]

  • 14. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ, Rivet JM, Canton H, Le Marouille-Girardon S, Gobert A.
    J Pharmacol Exp Ther; 1993 Mar 20; 264(3):1364-76. PubMed ID: 8450471
    [Abstract] [Full Text] [Related]

  • 15. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K.
    Eur J Pharmacol; 1986 May 27; 124(3):361-3. PubMed ID: 2942412
    [Abstract] [Full Text] [Related]

  • 16. Prior treatment with estrogen attenuates the effects of the 5-HT1A agonist, 8-OH-DPAT, on lordosis behavior.
    Jackson A, Uphouse L.
    Horm Behav; 1996 Jun 27; 30(2):145-52. PubMed ID: 8797023
    [Abstract] [Full Text] [Related]

  • 17. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain.
    Frankfurt M, McKittrick CR, Mendelson SD, McEwen BS.
    Neuroendocrinology; 1994 Mar 27; 59(3):245-50. PubMed ID: 8159274
    [Abstract] [Full Text] [Related]

  • 18. Intrahypothalamic 5,7-dihydroxytryptamine: temporal analysis of effects on 5-hydroxytryptamine content in brain nuclei and on facilitated lordosis behavior.
    Frankfurt M, Renner K, Azmitia E, Luine V.
    Brain Res; 1985 Aug 05; 340(1):127-33. PubMed ID: 4027638
    [Abstract] [Full Text] [Related]

  • 19. The differential effects of food restriction on 5-HT1A and 5-HT1B receptor mediated control of serotonergic transmission in the hippocampus and hypothalamus of rats.
    Gur E, Newman ME, Avraham Y, Dremencov E, Berry EM.
    Nutr Neurosci; 2003 Jun 05; 6(3):169-75. PubMed ID: 12793521
    [Abstract] [Full Text] [Related]

  • 20. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L, Maswood S, Jackson A.
    Pharmacol Biochem Behav; 2000 Jun 05; 66(2):383-8. PubMed ID: 10880694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.